Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction.
about
Heart Failure: Diagnosis, Management and UtilizationExercise intolerance in heart failure with preserved ejection fraction: more than a heart problemHeart failure with preserved ejection fraction: mechanisms, clinical features, and therapiesThe cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionImproved arterial-ventricular coupling in metabolic syndrome after exercise training: a pilot study.Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction.Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction.Update on heart failure with preserved ejection fraction.Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studyExercise physiology in heart failure and preserved ejection fraction.Impact of lifelong exercise "dose" on left ventricular compliance and distensibility.Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fractionPARIS: A good start for exercise in HFPEF.Role of physical training in heart failure with preserved ejection fractionTowards 'Eternal Youth' of cardiac and skeletal muscle.Ergospirometry and echocardiography in early stage of heart failure with preserved ejection fraction and in healthy individuals.Differential Responses of Post-Exercise Recovery of Leg Blood Flow and Oxygen Uptake Kinetics in HFpEF versus HFrEFExercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization.Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.Heart failure in older adults: embracing complexity.The Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection FractionSarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction.Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials.Exercise training as therapy for heart failure: current status and future directions.Arterial stiffness and walk time in patients with end-stage renal diseasePulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction.Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass.Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fractionPhenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fractionEffect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trialCardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.Effects of exercise on cardiovascular performance in the elderly.Heart failure with preserved ejection fraction in the elderly: scope of the problem.Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.The effect of lifelong exercise dose on cardiovascular function during exercise.Heart failure with preserved ejection fraction: current understandings and challenges.A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group.Changes in cardiopulmonary reserve and peripheral arterial function concomitantly with subclinical inflammation and oxidative stress in patients with heart failure with preserved ejection fraction
P2860
Q26745543-E994D06E-2734-4E67-B7E2-E77084DA98B7Q26991985-1E53F5EB-22CC-4283-AE19-D5E15C837648Q27000263-2D0E6C30-BD14-4E4F-89A6-29BF60890576Q27024279-0336EE1F-2350-45A7-B4F7-C3511E4A9677Q30394959-8BBA3B0F-99B8-478E-A503-EC3C199682CCQ30452450-BB588716-6397-42AE-9D8B-0702A19578A0Q33568831-0BEDC4DF-98E6-43F6-A3AA-4F334187E160Q33640339-85AF5CBD-86D5-4E11-A2E2-EF944E0BEE1DQ33992679-0818ECCF-BBA6-4876-B539-71B3F2F02836Q34053617-5AFE385C-21E5-4429-8984-D7F5CA2B48BCQ34743731-98D10D52-E351-4309-B9F8-6E9C6D4D8C64Q34803690-19F8F82D-CCCB-46D8-88E3-60BD42BDC26BQ35156611-63FDF59E-5B2A-4F5E-9DA6-0699B74F33DCQ35556222-DFFB563B-7C12-4855-AB8B-88A660BA8E39Q35662642-3793955E-2015-4E03-A5DD-18EEF4A55CB3Q36117014-4A07ED4A-8868-496A-8498-B97AEF6FFC3EQ36152668-CABDA967-98DB-42D9-8CCB-F5B6275F3669Q36339431-6190317E-5D44-40F0-A947-A89F85439BC8Q36395089-95148D62-CFF4-4C51-90D4-4577509F0DC8Q36578414-CC5E08D8-CBE7-4183-9D43-E9DFE508541FQ36584873-6E4B17A7-E005-40DB-8571-131EE719C562Q36683918-E72DFC3A-F885-4BB0-AC2B-CF111B76FAB8Q36687730-D9FDD7BB-8746-40A7-884B-C205E6BDCE5FQ36713772-94887E0E-B422-4CB3-958A-9163766B4E8AQ37013455-2DF02ED8-FD0E-4026-9362-57583667982BQ37015819-E379AA43-C0F6-4FBC-A87E-32649B9D92A2Q37015838-618BCC2C-BE83-4B2B-802E-FDE4C6D731CAQ37015935-231CA89A-7B48-4D8C-B5E1-D5D71EF2AFB1Q37055336-7549935F-209B-4D57-ABBB-40152BE43822Q37058596-5230F0C4-C09F-4E31-A53B-8FB53CAA824DQ37074089-96A618AD-36F8-4951-9D0B-79231CEE9377Q37086510-1E3EB422-71D2-464B-AD8E-62453EC4E761Q37380080-0CDBB941-8A20-48A9-8A02-65625AB95E22Q37594289-523FDA27-7279-48AA-885E-5F98B3B80BF4Q37633991-1B383878-5AF8-4B38-9EF7-6E409B568C53Q37678145-378132C5-AFC7-4BFA-ABE9-095CABE4D384Q37679359-392F0CEB-AD40-4DBB-B83D-00403AB7BF76Q38217344-51B255AC-697D-4CCD-AA3F-47512C3D8B9BQ38267856-6F330F52-97F9-42BB-8D17-1D4A546E179AQ38285243-3BFF62DD-9E6E-4B80-9D81-158EB9351851
P2860
Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Abnormal haemodynamic response ...... h preserved ejection fraction.
@ast
Abnormal haemodynamic response ...... h preserved ejection fraction.
@en
type
label
Abnormal haemodynamic response ...... h preserved ejection fraction.
@ast
Abnormal haemodynamic response ...... h preserved ejection fraction.
@en
prefLabel
Abnormal haemodynamic response ...... h preserved ejection fraction.
@ast
Abnormal haemodynamic response ...... h preserved ejection fraction.
@en
P2093
P2860
P356
P1476
Abnormal haemodynamic response ...... h preserved ejection fraction.
@en
P2093
Anand Prasad
Benjamin D Levine
Beverley Adams-Huet
Bradley R Newcomer
Eric L Pacini
Jeff L Hastings
Katja Heinicke
M Dean Palmer
Paul S Bhella
Shigeki Shibata
P2860
P304
P356
10.1093/EURJHF/HFR133
P577
2011-10-05T00:00:00Z